NovMetaPharma Co Ltd
229500
Company Profile
Business description
NovMetaPharma Co Ltd researches and develops new medicines and health supplements for metabolic diseases. The company also sells C01 and CZ raw materials to partners conducting joint research and development, and also sells health functional foods.
Contact
727 Eonju-ro
13th floor, Nonhyeon-dong, Trees Building
Gangnam-gu
Seoul
KORT: +82 25381893
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
20
Stocks News & Analysis
stocks
Sales shine but broader macro outlook darkens for this ASX share
US stores are struggling, but our investment thesis hinges on the Australian rollout.
stocks
Chart of the Week: US equity market trading at an attractive discount
The latest from our Chief US Market Strategist.
stocks
Undervalued ASX share retains wide moat rating despite regulatory pressures
Proposed price regulation impacts our fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,149.20 | 24.10 | 0.26% |
| CAC 40 | 8,263.87 | 355.13 | 4.49% |
| DAX 40 | 24,080.63 | 1,159.04 | 5.06% |
| Dow JONES (US) | 47,909.92 | 1,325.46 | 2.85% |
| FTSE 100 | 10,608.88 | 260.09 | 2.51% |
| HKSE | 25,808.00 | 85.02 | -0.33% |
| NASDAQ | 22,634.99 | 617.14 | 2.80% |
| Nikkei 225 | 55,861.55 | 446.87 | -0.79% |
| NZX 50 Index | 13,278.48 | 24.54 | 0.19% |
| S&P 500 | 6,782.81 | 165.96 | 2.51% |
| S&P/ASX 200 | 8,949.70 | 34.30 | 0.38% |
| SSE Composite Index | 3,965.70 | 29.30 | -0.73% |